Found: 19
Select item for more details and to access through your institution.
A microchip flow‐chamber assay screens congenital primary hemostasis disorders.
- Published in:
- Pediatrics International, 2021, v. 63, n. 2, p. 160, doi. 10.1111/ped.14378
- By:
- Publication type:
- Article
Emicizumab‐mediated haemostatic function in patients with haemophilia A is down‐regulated by activated protein C through inactivation of activated factor V.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 2, p. 257, doi. 10.1111/bjh.15525
- By:
- Publication type:
- Article
Factor (F)VIII/VIIa enhances global haemostatic function in the co-presence of bypassing agents and FVIII among patients with haemophilia A with inhibitor.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 528, doi. 10.1111/bjh.15209
- By:
- Publication type:
- Article
Different factor VIII neutralizing effects on anti-factor VIII inhibitor antibodies associated with epitope specificity and von Willebrand factor.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 1, p. 104, doi. 10.1111/bjh.12473
- By:
- Publication type:
- Article
Correlations between global clotting function tests, duration of operation, and postoperative chest tube drainage in pediatric cardiac surgery.
- Published in:
- Pediatric Anesthesia, 2011, v. 21, n. 8, p. 865, doi. 10.1111/j.1460-9592.2011.03524.x
- By:
- Publication type:
- Article
Emicizumab-mediated hemostatic function assessed by thrombin generation assay in an in vitro model of factor VIII-depleted thrombophilia plasma.
- Published in:
- International Journal of Hematology, 2024, v. 119, n. 2, p. 109, doi. 10.1007/s12185-023-03683-y
- By:
- Publication type:
- Article
Longitudinal dynamic changes in factor VIII inhibitor titers in patients with hemophilia A and inhibitors receiving emicizumab prophylaxis.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 6, p. 690, doi. 10.1007/s12185-023-03667-y
- By:
- Publication type:
- Article
Comparisons of global coagulation potential and bleeding episodes in emicizumab-treated hemophilia A patients and mild hemophilia A patients.
- Published in:
- International Journal of Hematology, 2022, v. 115, n. 4, p. 489, doi. 10.1007/s12185-021-03276-7
- By:
- Publication type:
- Article
Comprehensive blood coagulation potential in patients with acquired hemophilia A: retrospective analyses of plasma samples obtained from nationwide centers across Japan.
- Published in:
- International Journal of Hematology, 2022, v. 115, n. 2, p. 163, doi. 10.1007/s12185-021-03249-w
- By:
- Publication type:
- Article
Evaluation of clinical severity in patients with type 2N von Willebrand disease using microchip-based flow-chamber system.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Global coagulation function assessed by rotational thromboelastometry predicts coagulation-steady state in individual hemophilia A patients receiving emicizumab prophylaxis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Coagulant potentials of emicizumab in the plasmas from infant and toddler patients with hemophilia A.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 10, p. 1, doi. 10.1002/pbc.30590
- By:
- Publication type:
- Article
Spotlight on emicizumab in the management of hemophilia A: patient selection and special considerations.
- Published in:
- Journal of Blood Medicine, 2019, v. 10, p. 171, doi. 10.2147/JBM.S175952
- By:
- Publication type:
- Article
Force‐sensing treadmill gait analysis system can detect gait abnormalities in haemophilia patients without arthropathy.
- Published in:
- Haemophilia, 2024, v. 30, n. 3, p. 780, doi. 10.1111/hae.14987
- By:
- Publication type:
- Article
Clinical conditions and risk factors for inhibitor‐development in patients with haemophilia: A decade‐long prospective cohort study in Japan, J‐HIS2 (Japan Hemophilia Inhibitor Study 2).
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. 745, doi. 10.1111/hae.14602
- By:
- Publication type:
- Article
Assessment of self‐/parent‐reported quality of life in Japanese children with haemophilia using the Japanese version of KIDSCREEN‐52.
- Published in:
- Haemophilia, 2020, v. 26, n. 2, p. 243, doi. 10.1111/hae.13945
- By:
- Publication type:
- Article
Whole blood ristocetin‐induced platelet impedance aggregometry does not reflect clinical severity in patients with type 1 von Willebrand disease.
- Published in:
- Haemophilia, 2019, v. 25, n. 3, p. e174, doi. 10.1111/hae.13725
- By:
- Publication type:
- Article
A case of moderate haemophilia A with inhibitor, carrying the p.R1800H mutation, complicated with juvenile idiopathic arthritis.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Hemostatic Treatment Using Factor VIII Concentrates for Neutralizing High-Responding Inhibitors Prior to CVAD Insertion for Immune-Tolerance Induction Therapy.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2012, v. 18, n. 1, p. 66, doi. 10.1177/1076029611412364
- By:
- Publication type:
- Article